NEW YORK (GenomeWeb News) — Third Wave Technologies has pocketed $14.9 million after closing the sale of its previously announced zero-coupon convertible notes, the company said today.
 
Third Wave said it intends to use the cash infusion for general corporate expenses.
 
Third Wave said it would place the notes with an unnamed institutional investor on Dec. 19.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.